BG104400A - Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists - Google Patents
Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonistsInfo
- Publication number
- BG104400A BG104400A BG104400A BG10440000A BG104400A BG 104400 A BG104400 A BG 104400A BG 104400 A BG104400 A BG 104400A BG 10440000 A BG10440000 A BG 10440000A BG 104400 A BG104400 A BG 104400A
- Authority
- BG
- Bulgaria
- Prior art keywords
- receptor antagonists
- acid derivatives
- endothelin receptor
- producing
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19750529A DE19750529A1 (de) | 1997-11-14 | 1997-11-14 | Neue heterocyclisch substituierte alpha-Hydroxycarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
PCT/EP1998/007026 WO1999025701A1 (de) | 1997-11-14 | 1998-11-04 | NEUE HETEROCYCLISCH SUBSTITUIERTE α-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104400A true BG104400A (en) | 2001-01-31 |
Family
ID=7848772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104400A BG104400A (en) | 1997-11-14 | 2000-05-04 | Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
Country Status (23)
Country | Link |
---|---|
US (1) | US6358983B1 (xx) |
EP (1) | EP1037883A1 (xx) |
JP (1) | JP2001523671A (xx) |
KR (1) | KR20010032083A (xx) |
CN (1) | CN1278805A (xx) |
AR (1) | AR017581A1 (xx) |
AU (1) | AU752165B2 (xx) |
BG (1) | BG104400A (xx) |
BR (1) | BR9814157A (xx) |
CA (1) | CA2308746A1 (xx) |
CO (1) | CO4990973A1 (xx) |
DE (1) | DE19750529A1 (xx) |
HR (1) | HRP980591A2 (xx) |
HU (1) | HUP0004341A3 (xx) |
ID (1) | ID24819A (xx) |
IL (1) | IL135461A0 (xx) |
NO (1) | NO20002154L (xx) |
NZ (1) | NZ504289A (xx) |
PL (1) | PL340756A1 (xx) |
SK (1) | SK4932000A3 (xx) |
TR (1) | TR200001365T2 (xx) |
WO (1) | WO1999025701A1 (xx) |
ZA (1) | ZA9810425B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1750862T3 (pl) * | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1997
- 1997-11-14 DE DE19750529A patent/DE19750529A1/de not_active Withdrawn
-
1998
- 1998-11-04 KR KR1020007005207A patent/KR20010032083A/ko not_active Application Discontinuation
- 1998-11-04 NZ NZ504289A patent/NZ504289A/en unknown
- 1998-11-04 SK SK493-2000A patent/SK4932000A3/sk unknown
- 1998-11-04 HU HU0004341A patent/HUP0004341A3/hu unknown
- 1998-11-04 EP EP98958900A patent/EP1037883A1/de not_active Withdrawn
- 1998-11-04 TR TR2000/01365T patent/TR200001365T2/xx unknown
- 1998-11-04 PL PL98340756A patent/PL340756A1/xx not_active Application Discontinuation
- 1998-11-04 ID IDW20000882A patent/ID24819A/id unknown
- 1998-11-04 CA CA002308746A patent/CA2308746A1/en not_active Abandoned
- 1998-11-04 WO PCT/EP1998/007026 patent/WO1999025701A1/de not_active Application Discontinuation
- 1998-11-04 AU AU14878/99A patent/AU752165B2/en not_active Ceased
- 1998-11-04 BR BR9814157-0A patent/BR9814157A/pt not_active IP Right Cessation
- 1998-11-04 US US09/530,382 patent/US6358983B1/en not_active Expired - Fee Related
- 1998-11-04 CN CN98811085A patent/CN1278805A/zh active Pending
- 1998-11-04 IL IL13546198A patent/IL135461A0/xx unknown
- 1998-11-04 JP JP2000521084A patent/JP2001523671A/ja active Pending
- 1998-11-09 AR ARP980105651A patent/AR017581A1/es not_active Application Discontinuation
- 1998-11-13 CO CO98067231A patent/CO4990973A1/es unknown
- 1998-11-13 HR HR19750529.5A patent/HRP980591A2/hr not_active Application Discontinuation
- 1998-11-13 ZA ZA9810425A patent/ZA9810425B/xx unknown
-
2000
- 2000-04-27 NO NO20002154A patent/NO20002154L/no not_active Application Discontinuation
- 2000-05-04 BG BG104400A patent/BG104400A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20002154L (no) | 2000-05-12 |
TR200001365T2 (tr) | 2000-09-21 |
HUP0004341A3 (en) | 2001-12-28 |
US6358983B1 (en) | 2002-03-19 |
BR9814157A (pt) | 2000-10-03 |
DE19750529A1 (de) | 1999-05-20 |
SK4932000A3 (en) | 2001-02-12 |
CO4990973A1 (es) | 2000-12-26 |
KR20010032083A (ko) | 2001-04-16 |
HUP0004341A1 (hu) | 2001-10-28 |
NO20002154D0 (no) | 2000-04-27 |
NZ504289A (en) | 2002-03-01 |
EP1037883A1 (de) | 2000-09-27 |
AR017581A1 (es) | 2001-09-12 |
JP2001523671A (ja) | 2001-11-27 |
CA2308746A1 (en) | 1999-05-27 |
AU1487899A (en) | 1999-06-07 |
HRP980591A2 (en) | 1999-08-31 |
AU752165B2 (en) | 2002-09-05 |
PL340756A1 (en) | 2001-02-26 |
ZA9810425B (en) | 2000-05-15 |
ID24819A (id) | 2000-08-24 |
IL135461A0 (en) | 2001-05-20 |
WO1999025701A1 (de) | 1999-05-27 |
CN1278805A (zh) | 2001-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL66596A0 (en) | Antihypertensive substituted n-alkanoylheterocyclic carboxylic acid derivatives,compositions containing them and methods for their use | |
BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
ES8802023A1 (es) | Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos | |
HUT76476A (en) | Morpholine and thiomorpholine derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
HUT53619A (en) | Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same | |
BG100661A (en) | Aryl acetic acid derivatives | |
ES8406193A1 (es) | Procedimiento para la preparacion de nuevas 1,4-dihidropiridinas sustituidas | |
MY137356A (en) | Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta-opioid agonists | |
MXPA02001329A (es) | Amidas de acido carboxilico, su produccion y su uso como medicamentos. | |
BG104400A (en) | Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists | |
ES8603184A1 (es) | Metodo de preparar un derivado de acido b-carbolin-3-carbo- xilico | |
MY113529A (en) | New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them | |
ATE151750T1 (de) | 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind | |
MY121785A (en) | Hydroxamic acid derivatives as inhibitors of the production of soluble cd23 | |
IL115085A0 (en) | Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
HUT55009A (en) | Process for producing imidazolyl and pyridyl derivatives of phenyl-substituted 1,4-dihydropyridines and pharmaceutical compositions comprising same | |
ES8603871A1 (es) | Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina | |
BG105618A (en) | Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists | |
GB9806358D0 (en) | Synthesis of carboxylic acid derivatives | |
ES8600258A1 (es) | Procedimiento de preparar derivados triazolicos | |
DE60105402D1 (en) | Arthropodische carboxanilide | |
GB1315995A (en) | Substituted azetidinones |